Restoration of the type I IFN–IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in NOD mice-Reference-Cited by-同舟云学术

Restoration of the type I IFN–IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in NOD mice

Published:2018-02-08 Issue:3 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Rahman M. Jubayer,Rodrigues Kameron B.^ORCID,Quiel Juan A.,Liu Yi,Bhargava Vipul,Zhao Yongge,Hotta-Iwamura Chie,Shih Han-Yu^ORCID,Lau-Kilby Annie W.,Malloy Allison M.W.,Thoner Timothy W.,Tarbell Kristin V.

Funder

National Institute of Health, USA

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/97843/files/pdf

Reference68 articles.

1. Etiology of Type 1 Diabetes

2. Identification of a Molecular Signature in Human Type 1 Diabetes Mellitus Using Serum and Functional Genomics

3. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

4. Structural basis for the killing of human beta cells by CD8+ T cells in type 1 diabetes

5. Interferon- initiates type 1 diabetes in nonobese diabetic mice

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gαz-independent and -dependent Improvements With EPA Supplementation on the Early Type 1 Diabetes Phenotype of NOD Mice;Journal of the Endocrine Society;2024-05-21

2. Fatty acid-mediated signaling as a target for developing type 1 diabetes therapies;Expert Opinion on Therapeutic Targets;2023-09-02

3. Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis;Frontiers in Pharmacology;2022-11-11

4. Effects of Arachidonic Acid and Its Metabolites on Functional Beta-Cell Mass;Metabolites;2022-04-12

5. Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?;Journal of Personalized Medicine;2022-03-29